ARVO announces recipients of the 2025 ARVO Foundation Early Career Clinician-Scientist Awards

(Image Credit: AdobeStock/ATKWORK888)

The Association for Research in Vision and Ophthalmology (ARVO) Foundation has announced Maria Vittoria Cicinelli, MD, Denise Loya-Garcia, MD, PhD, and Vishal Raval, MD, as the recipients of the 2025 ARVO Foundation Early Career Clinician-Scientist Award.

Researchers engaged in basic or clinical vision research who hold an MD or equivalent clinical professional degree with an academic faculty or comparable appointment, are committed to a career encompassing institutionally guaranteed protected time for research, and are currently working or have previously worked under the guidance of a mentor are eligible for the award.

The recipients of the award will receive a $3,000 honorarium.

Maria Vittoria Cicinelli, MD

Maria Vittoria Cicinelli, MD, San Raffaele Scientific Institute, Italy, is an assistant professor with primary areas of expertise in medical retina and uveitis. Cicinelli has conducted research investigating the progression of pachychoroid disease by identifying distinct phenotypic clusters using multimodal imaging and machine learning.

Cicinelli stated in a release from ARVO that "this study provides insights into the natural history of pachychoroid disease, highlighting the relative stability of advanced disease stages and the dynamic nature of earlier forms.”

Commenting on receiving the award, Cicinelli said, "This experience has reinforced the importance of pushing boundaries—both in research and in the limits we set for ourselves. It serves as a valuable lesson for early-career scientists like myself, and I hope it inspires others to embrace challenges, explore new methodologies, and pursue their talents with confidence.”

Denise Loya-Garcia, MD, PhD, Instituto de Oftalmología Fundación Conde de Valenciana, Mexico, is an ophthalmologist specializing in cornea, refractive surgery, and external diseases. She is researching the long-term outcomes of the Boston Keratoprosthesis (KPro), an artificial cornea designed to help people with severe corneal blindness when traditional corneal transplants are not an option, in Latin America.

Denise Loya-Garcia, MD, PhD

Loya-Garcia commented on the award in a press release from ARVO.

"Being recognized with an award is both an honor and a reminder of the responsibility that comes with it," Loya-Garcia said. “While such recognition acknowledges dedication and effort and creates opportunities for future collaboration, it also serves as a call to action—to pay it forward. Just as we have been guided, supported, and given opportunities by others, we must do the same for those who follow. True success is not measured only by personal achievements but by the impact we have on others, ensuring that the knowledge, support, and opportunities we received continue to inspire and uplift future generations.”

Vishal Raval, MD (Photos courtesy ARVO)

The final recipient, Vishal Raval, MD, LV Prasad Eye Institute, India, is currently pursuing a PhD in the field of novel drug delivery treatment for retinoblastoma. Raval notes that his proposed research will have an inherent public health impact on developing nations that are carrying retinoblastoma’s global burden. Raval will test the working hypothesis that applying a dissolvable polymer-based microneedle patch loaded with topotecan on the sclera will achieve therapeutic target levels in choroid-retinal complex.

“What is widely used in developed nations does not apply to populations in developing nations with low incomes, lack of infrastructure, and limited access to technologically complex treatment in countries like India,” Raval explained. “Considering the high cost and technical complexity of IAC (intra-arterial chemotherapy) and the lack of cultural acceptance of the alternative (enucleation), there is an urgent need to develop new drug delivery approaches that are effective yet easy to administer.”

Commenting on the award, Raval said, "This validates the hard work and dedication of my team and serves as a motivator for further research... Overall, this award is not just an accolade, but a significant catalyst that will propel my research career forward, allow me to make a greater impact in the field, and help me pursue my dream of becoming a true clinician-scientist."

Reference:

1. Recipients of ARVO Foundation Early Career Clinician-Scientist Research Awards announced. Published March 12, 2025. Accessed March 13, 2025.https://www.newswise.com/articles/recipients-of-arvo-foundation-early-career-clinician-scientist-research-awards-announced